Risks for retinoblastoma

Last medical review:

Some things can affect your risk, or chance, of developing cancer. Certain behaviours, substances or conditions can increase or decrease the risk. Most cancers are the result of many risks. Childhood cancers are rare and there is less known about the risks. Most risks for childhood cancer are not modifiable. This means that you can’t change them.

A mutation, or change, in the retinoblastoma 1 (RB1) gene is the main risk for retinoblastoma.

Retinoblastoma accounts for about 2% of all cancers that occur in children, from birth to 14 years of age, and is the most common eye cancer in children. Most cases of retinoblastoma are diagnosed in children younger than 2 years old.

The following can increase the risk for retinoblastoma. None of these risks can be changed. Until we learn more about these risks, there are no specific ways to lower the risk for retinoblastoma.

RB1 gene mutation

Genetic mutations are changes to a gene. Some gene changes can increase the risk of developing certain types of cancer. Inherited gene mutations are passed on from a parent to a child.

The eye starts to develop well before birth. Retinoblastoma is caused by a mutation to the RB1 gene in the immature cells of the retina (called retinoblasts). This mutation causes the retinoblasts to grow out of control.

There are 2 copies of the RB1 gene in every cell – one from each parent. There must be a change in both copies of the RB1 gene in a retinoblast for a retinoblastoma tumour to develop.

There are 2 different types of retinoblastoma. The type depends on where and when the RB1 mutation occurs and whether the mutation is inherited (passed to a child from a parent).

Non-heritable retinoblastoma (also called sporadic retinoblastoma) happens by chance. Children are born with 2 normal copies of the RB1 gene. A mutation of both copies of the RB1 gene in a retinoblast cell that occurs after birth causes a retinoblastoma tumour to form in the eye. Children with non-heritable retinoblastoma develop one tumour in one eye (called unilateral retinoblastoma). They will not pass the RB1 mutation on to their children. About half of retinoblastomas are non-heritable.

Heritable retinoblastoma is a result of a mutation in the RB1 gene that is either inherited, or the mutation happens in the egg or sperm before or soon after conception (called a germline mutation) or when the embryo is developing. In all cases of heritable retinoblastoma, a child is born with one copy of the RB1 mutation in all cells or in a portion of all cells of the body. This increases the risk of developing cancer in other parts of the body later in life. A mutation of the second copy of the RB1 gene then occurs in retinoblasts and causes retinoblastoma to form. In about 10% of children with heritable retinoblastoma, the mutation of the second copy of the RB1 gene was inherited from a parent. When this happens, it’s called familial retinoblastoma.

Children with heritable retinoblastoma can have more than one tumour and these tumours can develop in one or both eyes (called bilateral retinoblastoma). Children with heritable retinoblastoma can pass the RB1 mutation on to their children. About half of children with retinoblastoma have heritable retinoblastoma.

Children with heritable retinoblastoma have a higher risk of developing tumours in the pineal gland (called trilateral retinoblastoma). The pineal gland is located in the brain and controls the sleep cycle. Trilateral retinoblastoma usually occurs in children aged 20 to 36 months old.

Children with heritable retinoblastoma also have a higher risk of developing these other types of cancer later in life:

  • bone cancer
  • soft tissue sarcoma
  • melanoma skin cancer

Amplification of the MYCN gene

A small number of children with retinoblastoma don't have an RB1 mutation. Instead, retinoblastoma is caused by an increased number of copies (called amplification) of the MYCN gene. The amplification of the MYCN gene causes retinoblastoma that grows quickly in one eye and usually occurs in children around the age of 4 months old.

Possible risks

The following have been linked with retinoblastoma, but more research is needed to know for sure that they are risks.

  • being born to older parents
  • being born to a parent who smoked while pregnant

Expert review and references

  • Canadian Cancer Society | Société canadienne du cancer
  • American Cancer Society. Retinoblastoma. 2018. https://www.cancer.org/.
  • Azary S, Ganguly A, Bunin GR, Lombardi C et al. Sporadic retinoblastoma and parental smoking and alcohol consumption before and after conception: a report from the Children's Oncology Group. PLoS One. 2016.
  • Bradbury BD & Jick H. In vitro fertilization and childhood retinoblastoma. British Journal of Clinical Pharmacology. Wiley Online; 2004.
  • Bunin GR, Felice MA, Davidson W, et al. Medical radiation exposure and risk of retinoblastoma resulting from new germline RB1 mutation. International Journal of Cancer. Hoboken, NJ: Wiley-Liss, Inc; 2011.
  • Bunin GR, Meadows AT, Emanuel BS, et al. Pre- and postconception factors associated with sporadic heritable and nonheritable retinoblastoma. Cancer Research. American Association for Cancer Research; 1989.
  • Bunin GR, Petrakova A, Meadows AT, et al. Occupations of parents of children with retinoblastoma: a report from the Children's Cancer Study Group. Cancer Research. American Association for Cancer Research; 1990.
  • Cancer Research UK. Retinoblastoma. 2024. https://www.cancerresearchuk.org/.
  • DerKinderen DJ, Koten JW, Tan KE, et al. Parental age in sporadic hereditary retinoblastoma. American Journal of Ophthalmology. Elsevier; 1990.
  • Dockerty JD, Draper G, Vincent T, et al. Case-control study of parental age, parity and socioeconomic level in relation to childhood cancers. International Journal of Epidemiology. Oxford, UK: Oxford Journals Oxford University Press; 2001.
  • Heck JE, Contreras ZA, Park AS, Davidson TB, Cockburn M, Ritz B. Smoking in pregnancy and risk of cancer among young children: a population-based study. International Journal of Cancer. 2016.
  • Hurwitz RL, Shields CL, Shields JA et al. Retinoblastoma. Pizzo PA & Poplack DG (eds.). Principles and Practice of Pediatric Oncology. 7th ed. Philadelphia: Wolters Kluwer; 2016: 27: 700-725.
  • Retinoblastoma. Janes-Hodder, H. & Keene, N. Childhood Cancer - A Parent's Guide to Solid Tumor Cancers. 2nd ed. O'Reilly; 2002: 13: pp.193-205.
  • Leahey AM, Gombos DS, Chevez-Barrios P. Retinoblastoma. Blaney SM, Adamson PC, Helman LJ (eds.). Pizzo and Pollack's Pediatric Oncology. 8th ed. Wolters Kluwer; 2021: Kindle version, [chapter 32] https://read.amazon.ca/?asin=B08DVWZNVP&language=en-CA.
  • Lohmann DR, Gallie BL. Retinoblastoma. GeneReviews [Internet]. National Library of Medicine (NLM); 2023.
  • MacCarthy A, Bunch KJ, Fear NT, et al. Paternal occupation and retinoblastoma: a case-control study based on data for Great Britain 1962-1999. Occupational and Environmental Medicine. BMJ Publishing Group; 2009.
  • Marees T, Dommering CJ, Imhof SM, et al. Incidence of retinoblastoma in Dutch children conceived by IVF: an expanded study. Human Reproduction. Oxford University Press; 2009.
  • Martini FH, Tallitsch RB. Nath JL. Human Anatomy. 9th ed. New York, NY: Pearson; 2018.
  • Moll AC, Imhof SM, Cruysberg JR, et al. Incidence of retinoblastoma in children born after in-vitro fertilisation. Lancet. New York, NY: Elsevier, Inc; 2003.
  • Moll AC, Imhof SM, Kuik DJ, et al. High parental age is associated with sporadic hereditary retinoblastoma: the Dutch retinoblastoma register 1862-1994. Human Genetics. Springer; 1996.
  • OncoLink. All About Retinoblastoma. Trustees of the University of Pennsylvania; 2020. https://www.oncolink.org/.
  • PDQ® Pediatric Treatment Editorial Board. Retinoblastoma Treatment (PDQ®) – Health Professional Version. Bethesda, MD: National Cancer Institute; 2024. https://www.cancer.gov/.
  • Robert C, Karaszewska B, Schachter J, et al. Improved overall survival in melanoma with combined dabrafenib and trametinib. Lancet Oncology. 372(1):30-39.
  • Roman E, Lightfoot T, Picton S, Kinsey S. Childhood cancers. Thun MJ, Linet MS, Cerhan JR, Haiman CA Schottenfeld D, eds.. Schottenfeld and Fraumeni Cancer Epidemiology and Prevention. 4th ed. New York, NY: Oxford University Press; 2018: Kindle version, 59 https://read.amazon.ca/?asin=B0777JYQQC&language=en-CA.
  • Stavrou EP, Baker DF, Bishop JF. Maternal smoking during pregnancy and childhood cancer in New South Wales: a record linkage investigation. Cancer Causes & Control. Springer; 2009.
  • Theriault BL, Dimaras H, Gallie BL, Corson TW. The genomic landscape of retinoblastoma: a review. Clinical and Experimental Ophthalmology. 2014.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society